ENO1 and central nervous system cancer: Yet, despite a promising observation with CB-839 in vitro (Fig. 3 a-b), we found that in vivo, glutamine may not be a prominent anaplerotic substrate and that glucose-derived pyruvate predominantly drives anaplerosis, at least in ENO1-deleted gliomas (Figs. 5 and 6).